Kick off meeting, preclinical pharmacokinetic & pharmacology evaluations of agents being developed for cancer patients, 7/1/2016 - 9/30/16
Ended Awarded
- Contract number
- HHSN26100001
- Awardee
-
IIT Research Institute UEI DGBUFQYMKWB5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,010
Award facts
- Opportunity
-
- N02CM6700011 Solicitation number
- Preclinical Pharmacokinetic and Pharmacology Evaluations of Agents Being Developed for Cancer Patients Award Notice · Posted Feb 5, 2016
- Preclinical Pharmacokinetic and Pharmacological Studies Being Developed for Cancer Patients Award Notice · Posted Oct 6, 2015
- Contract value 100% obligated
- $1,010.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 5 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Chicago, IL 60616, USA
Award details come from SAM.gov/FPDS.
About this award
This is a $1,010.00 firm fixed-price delivery order awarded by the National Cancer Institute (NCI) to the IIT Research Institute (IITRI), a non-profit contract research organization. The contract is for a "Kick Off Meeting, Preclinical Pharmacokinetic & Pharmacology Evaluations of Agents Being Developed for Cancer Patients" with a performance period from July 1, 2016 to September 30, 2016. This work is being performed under NCI's Pharmacokinetic and Pharmacology Evaluations for Cancer Patients indefinite delivery/indefinite quantity (IDIQ) contract vehicle. IITRI has extensive experience conducting preclinical drug development services, including toxicology studies, safety assessments, and efficacy evaluations, to support Investigational New Drug (IND) applications for federal agencies. This specific task order does not have a set-aside designation.
Quick answers
Who was awarded contract HHSN26100001?
HHSN26100001 was awarded to IIT Research Institute by National Cancer Institute (National Institutes of Health) on July 1, 2016.
How much is contract HHSN26100001 worth?
The government has obligated $1,010 on HHSN26100001.
Is contract HHSN26100001 an order under another contract?
Yes. HHSN26100001 is a delivery order under HHSN261201600023I, an indefinite delivery contract, on Pharmacokinetic and Pharmacology Evaluations for Cancer Patients.
Was contract HHSN26100001 competed?
The extent of competition for HHSN26100001 was full and open competition. The government received 5 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award